United States · FDA National Drug Code directory
Buspirone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2237_d18097c5-1c0f-4a7d-b1ea-eeed4f02d038
- Product NDC
- 71335-2237
- Form
- TABLET
- Composition / generic term
- Buspirone hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230321
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 7.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-2237-1) · 71335-2237-1
- 90 TABLET in 1 BOTTLE (71335-2237-2) · 71335-2237-2
- 18 TABLET in 1 BOTTLE (71335-2237-3) · 71335-2237-3
- 28 TABLET in 1 BOTTLE (71335-2237-4) · 71335-2237-4
- 60 TABLET in 1 BOTTLE (71335-2237-5) · 71335-2237-5
- 120 TABLET in 1 BOTTLE (71335-2237-6) · 71335-2237-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →